
An advisory committee for the Food and Drug Administrating has voted to recommend emergency use of a booster short of Pfizer's vaccine in people aged over 65 and vulnerable people. If the FDA moves forward with the committee's recommendation, boosters will be offered to both groups.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.